找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Radionuclide Therapy; Recep Beki?,Berna Polack,Murat Fani Bozkurt Book 2022 The Editor(s) (if applicable) and The Author(s), under exclusi

[復(fù)制鏈接]
查看: 43769|回復(fù): 52
樓主
發(fā)表于 2025-3-21 19:28:26 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Radionuclide Therapy
編輯Recep Beki?,Berna Polack,Murat Fani Bozkurt
視頻videohttp://file.papertrans.cn/821/820878/820878.mp4
概述Represents an extensive source of information in the field of radionuclide therapy.Explores the current status of radionuclide therapy.Includes medical treatment information in diseases treated with r
圖書封面Titlebook: Radionuclide Therapy;  Recep Beki?,Berna Polack,Murat Fani Bozkurt Book 2022 The Editor(s) (if applicable) and The Author(s), under exclusi
描述The main purpose of this book is to create a reference for the indications, contraindications, patient selection, treatment practice, treatment side effect management, and follow-up of radionuclide treatments.. .Besides standard methods such as surgery, chemotherapy, radiotherapy, and hormone therapy, newly developed biological treatments, targeted treatments, personalized treatments, external beam radiotherapy, and targeted radionuclide treatments have begun to take their place in professional practice.?.Nuclear medicine, in addition to its role as a tracer of cancer, also assumes the role of treating with radioactive molecules directed to the cancer it traces. These traceable next-generation radionuclide treatments, whose efficacy and reliability have been proven and where diagnosis, treatment, and follow-up are carried out together, are increasingly included in oncology practice together with the new developed radiopharmaceuticals, ensuring a high rate of damage to cancer cells while protecting the surrounding normal tissues. Molecular cancer treatment will become more effective with individualized next-generation traceable radionuclide treatments, which will be shaped by geneti
出版日期Book 2022
關(guān)鍵詞Nuclear Medicine; Radiation; Radiopharmacy; Surgery; Hematology
版次1
doihttps://doi.org/10.1007/978-3-030-97220-2
isbn_softcover978-3-030-97222-6
isbn_ebook978-3-030-97220-2
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

書目名稱Radionuclide Therapy影響因子(影響力)




書目名稱Radionuclide Therapy影響因子(影響力)學(xué)科排名




書目名稱Radionuclide Therapy網(wǎng)絡(luò)公開度




書目名稱Radionuclide Therapy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Radionuclide Therapy被引頻次




書目名稱Radionuclide Therapy被引頻次學(xué)科排名




書目名稱Radionuclide Therapy年度引用




書目名稱Radionuclide Therapy年度引用學(xué)科排名




書目名稱Radionuclide Therapy讀者反饋




書目名稱Radionuclide Therapy讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 20:54:47 | 只看該作者
板凳
發(fā)表于 2025-3-22 04:16:50 | 只看該作者
Radionuclide Therapy in Neuroectodermal TumorsHigh-dose I-131 MIBG treatment in combination with megatherapy and stem cell transplantation in the high-risk patient group included in TPOG Neuroblastoma treatment protocol (NB2009) is carried out in a limited number of centers in Turkey since experienced personnel and equipped centers are required for this treatment.
地板
發(fā)表于 2025-3-22 05:06:25 | 只看該作者
Systemic Treatments and Related Side Effects in Neuroectodermal Tumors tumors in the WHO brain tumor classification published in 2016 [2]. This group includes medulloblastoma, neuroblastoma, ganglioneuroblastoma, medulloepithelioma, ependymoblastoma, and atypical teratoid/rhabdoid tumors. Most of the PNETs are located outside the CNS are from Ewing family of tumors.
5#
發(fā)表于 2025-3-22 09:22:07 | 只看該作者
des medical treatment information in diseases treated with rThe main purpose of this book is to create a reference for the indications, contraindications, patient selection, treatment practice, treatment side effect management, and follow-up of radionuclide treatments.. .Besides standard methods suc
6#
發(fā)表于 2025-3-22 13:12:40 | 只看該作者
7#
發(fā)表于 2025-3-22 20:12:44 | 只看該作者
8#
發(fā)表于 2025-3-22 23:14:34 | 只看該作者
9#
發(fā)表于 2025-3-23 04:08:05 | 只看該作者
Basic Properties and Preparation of Radiopharmaceuticals Used in Radionuclide Therapyiation is sent to the disease areas, thus providing treatment, control, or pain palliation of the disease. Damages caused by ionized radiation such as single or double-strand breaks in cell DNA and DNA base changes play a role in the effectiveness of treatment. A therapeutic radiopharmaceutical is a
10#
發(fā)表于 2025-3-23 06:00:11 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 06:29
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
土默特左旗| 定西市| 辉南县| 靖宇县| 乌拉特中旗| 明光市| 清徐县| 芜湖县| 鲁甸县| 乌兰察布市| 托克托县| 宁蒗| 长阳| 印江| 鄄城县| 邛崃市| 邵武市| 明光市| 略阳县| 宁津县| 青海省| 六枝特区| 剑川县| 进贤县| 海原县| 泗水县| 泰兴市| 施甸县| 左权县| 安平县| 康定县| 乌鲁木齐县| 定襄县| 丹巴县| 称多县| 武安市| 通辽市| 拜泉县| 锡林郭勒盟| 伊春市| 杭锦后旗|